IP Library Granted Patent US 6,927,069
Granted Patent B2
US 6,927,069 · App. 10/155,759 · Granted Aug 9, 2005

Organo luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,927,069
App. No.
10/155,759
Granted
Aug 9, 2005
Kind
B2
Abstract

A semiconductor nanocrystal compound is described capable of linking to an affinity molecule. The compound comprises (1) a semiconductor nanocrystal capable of emitting electromagnetic radiation and/or absorbing energy, and/or scattering or diffracting electromagnetic radiation—when excited by an electromagnetic radiation source or a particle beam; and (2) at least one linking agent, having a first portion linked to the semiconductor nanocrystal and a second portion capable of linking to an affinity molecule. The compound is linked to an affinity molecule to form a semiconductor nanocrystal probe capable of bonding with a detectable substance. Subsequent exposure to excitation energy will excite the semiconductor nanocrystal in the probe causing the emission of electromagnetic radiation. Further described are processes for respectively: making the luminescent semiconductor nanocrystal compound; making the semiconductor nanocrystal probe; and using the probe to determine the presence of a detectable substance in a material.

Claims (35)

1. A probe, comprising:

(a) a semiconductor nanocrystal which emits light when excited;

(b) a linking agent, linked to the semiconductor nanocrystal; and

(c) an affinity molecule linked to the linking agent.

2. The probe of claim 1 , wherein the affinity molecule is a biological material.

3. The probe of claim 1 , wherein the affinity molecule is an antibody.

4. The probe of claim 3 , wherein the antibody is a monoclonal antibody.

5. The probe of claim 3 , wherein the antibody is a polyclonal antibody.

6. The probe of claim 1 , wherein the affinity molecule is a nucleic acid.

7. The probe of claim 6 , wherein the nucleic acid is monomeric.

8. The probe of claim 6 , wherein the nucleic acid is oligomeric.

9. The probe of claim 1 , wherein the affinity molecule is a protein.

10. The probe of claim 1 , wherein the affinity molecule is a polysaccharide.

11. The probe of claim 1 , wherein the affinity molecule is a sugar.

12. The probe of claim 1 , wherein the affinity molecule is a peptide.

13. The probe of claim 1 , wherein the affinity molecule is a drug.

14. A coated structure, comprising:

a semiconductor nanocrystal core which emits light when excited; and

a coating comprised of silica glass positioned at least partially around the core.

15. The coated structure of claim 14 , wherein the glass comprises silica glass represented by the formula SiO x wherein x is selected from the group consisting of 1 and 2.

16. The coated structure of claim 14 , wherein the coating has a thickness in a range of from about 0.5 nm to about 10 nm.

17. The coated structure of claim 14 , wherein the coating has a thickness in a range of from about 0.5 nm to about 2 nm.

18. A composition, comprising:

a semiconductor nanocrystal which emits light when excited;

a polymer; and

an affinity molecule.

19. The composition as claimed in claim 18 , wherein the polymer encapsulates the semiconductor nanocrystal.

20. The composition as claimed in claim 18 , further comprising a first additional semiconductor nanocrystal which emits light when excited.

21. The composition as claimed in claim 18 , further comprising:

a plurality of additional semiconductor nanocrystals which emit light when excited.

22. A composition, comprising:

a plurality of semiconductor nanocrystals which emit light when excited;

a polymerizable linking agent encapsulating the nanocrystals; and

an affinity molecule.

23. The composition as claimed in claim 22 wherein the linking agent is comprised of a polymer and chosen from diacetylenes, acrylates, acrylamides, vinyl, and styryl.

Assignments (1)
CONFIRMATORY LICENSE Recorded Nov 3, 2008
From: STANFORD UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021775/0712 →